🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Canada / NCT07323875
Starting soon Not applicable

Single-Row Versus Double-Row Repair for Achilles Insertional Tendinopathy

NCT07323875 · tracked via the Priya Life Science Canada tracker
Phase
Not applicable
Started
2026-09
Last updated
2026-06-17

Condition(s) studied

Achilles Insertional TendinopathyAchilles Tendinopathy

Investigational drug(s) / intervention(s)

Single-row repair of the Achilles tendon at its calcaneal insertionDouble-row repair of the Achilles tendon at its calcaneal insertion

Single-row repair of the Achilles tendon at its calcaneal insertion: single-row (2 anchors)

Double-row repair of the Achilles tendon at its calcaneal insertion: double-row (4 anchors)

Study summary

Achilles insertional tendinopathy may require surgical debridement and tendon reattachment when non-operative treatment fails. Single-row and double-row repairs are used, with biomechanical studies favoring double-row, but clinical evidence of improved outcomes is lacking and costs are higher. This multi-center randomized trial will use the VISA-A score to compare outcomes and inform cost-effective, evidence-based surgical care.

Eligibility

Sex
ALL
Min age
18 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria: 1. Must be deemed to have capacity to provide informed consent; 2. Must sign and date the informed consent form; 3. Stated willingness to comply with all study procedures; 4. Adult patients between the ages of 18 and 75 years with symptomatic chronic Achilles insertional tendinopathy for a minimum of 3 months 5. Failure of non-operative management (which includes physiotherapy, stretching exercises, heel lifts, nonsteroidal anti-inflammatory drugs (NSAIDs), activity modification, etc.) for at least 3 months. 6. Preoperative imaging (x-ray and Medical Resonance Imaging (MRI)) is available and completed; 7. Willingness of patients to follow the postoperative rehabilitation protocol; 8. Willingness of patients to be available for follow up appointments for up to 2 years. Exclusion Criteria: 1. Non-insertional Achilles tendinopathy; 2. Achilles tendon rupture; 3. Previous Achilles tendon surgery; 4. Oral steroid use or steroid injection within 3 months of surgery; 5. History of connective tissue or collagen disorder (e.g. Marfan Syndrome) 6. History of chronic inflammatory disorders 7. History of neurological disease (stroke, cerebral palsy) 8. History of using more than 30mg of oxycodone or equivalent per day; 9. Current cigarette smoker (Former smokers must have quit for minimum of one year) 10. Diabetes type I or II 11. Pregnancy 12. Hypersensitivity to metal, Polylactic Acid (PLA), or Polyetheretherketone (PEEK) materials 13. Active infection 14. Worker's compensation claim (e.g. WSIB) 15. History of cognitive or mental health conditions that would make the participant unable to complete study procedures 16. Non-English speaking

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Women's College Hospital Toronto Ontario

More Women's College Hospital trials in Canada

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07323875 on ClinicalTrials.gov ↗ ← All trials in Canada